Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 06-2019 | |
| Sales | 10,313 | 12,318 | 12,886 | 9,359 | 0 |
| Cost of Goods | 8,245 | 9,325 | 10,122 | 7,614 | N/A |
| Gross Profit | 2,068 | 2,993 | 2,764 | 1,745 | N/A |
| Operating Expenses | 2,661 | 2,905 | 2,872 | 3,076 | 605 |
| Operating Income | -348 | 413 | 14 | -717 | -605 |
| Interest Expense | 335 | 374 | 394 | 380 | 0 |
| Other Income | 0 | 0 | 0 | 0 | -63 |
| Pre-tax Income | -683 | 39 | -380 | -1,097 | -668 |
| Income Tax | 432 | -5 | -1 | 16 | N/A |
| Net Income Continuous | -1,115 | 44 | -379 | -1,113 | -668 |
| Net Income | $-1,103 | $34 | $-381 | $-1,113 | $-668 |
| EPS Basic Total Ops | -7.20 | -6.33 | -8.43 | -12.91 | -10.00 |
| EPS Basic Continuous Ops | -7.07 | 0.28 | -2.40 | -7.06 | -12.28 |
| EPS Diluted Total Ops | -7.20 | -6.33 | -8.43 | -12.91 | -10.00 |
| EPS Diluted Continuous Ops | -7.07 | 0.28 | -2.40 | -7.06 | -12.28 |
| EBITDA(a) | $-404 | $537 | $136 | $-597 | $-605 |